Tech Company Financing Transactions
Acclinate Funding Round
Acclinate, operating out of Birmingham, raised $7 million in investment from Cencora Ventures, LabCorp and Latimer Ventures.
Transaction Overview
Company Name
Announced On
5/7/2024
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Series A
Investors
Proceeds Purpose
The funding will enable Acclinate to scale its impact in the clinical trial diversity and health equity landscapes.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
1143 1st Ave S. 114
Birmingham, AL 35233
USA
Birmingham, AL 35233
USA
Phone
Undisclosed
Website
Email Address
Overview
Acclinate was built to serve communities of color by members of that community. When I became a mom at 19, my son was diagnosed with asthma�he was hospitalized and given albuterol which unfortunately is less effective in 47% of African Americans.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Del Smith
Chief Marketing Officer
Ellie Newby
Chief Marketing Officer
Shayla Wilson
Chief Medical Officer
Camille Pope
Chief Operating Officer
Rosemary Robinson
VP - Bus. Development
Kyle Ashe
VP - Bus. Development
Tiffany Whitlow
VP - Product Management
Bryan Saxon
Browse more venture capital transactions:
Prev: 5/7/2024: Mavarick venture capital transaction
Next: 5/7/2024: Memo Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC transactions reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs